Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Nippon Shinyaku patents muscarinic acetylcholine M3 receptor positive allosteric modulators

June 9, 2021

BI-655064 does not meet CRR primary endpoint in lupus nephritis phase II trial

June 4, 2021

Pivotal study of venglustat in ADPKD stopped for futility

June 1, 2021

Targeting senescent cells restores kidney function

May 26, 2021

Regulus reports updated results from phase Ib study of RGLS-4326 in ADPKD

May 25, 2021

New phase Ib/IIa study evaluates VB-119 in membranous nephropathy

May 18, 2021

Dosing initiates in phase I study of GFB-024 in severe insulin-resistant diabetic nephropathy

May 14, 2021

Nephraegis Therapeutics to develop NPH-022 for the prevention and treatment of AKI

May 13, 2021

Phase III FIGARO-DKD cardiovascular outcomes study of finerenone meets primary endpoint

May 10, 2021

Benlysta approved in E.U. for active lupus nephritis

May 6, 2021

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...